Adze1.C

· Adze Biotechnology Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adze1.C, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma [Phase 1]